Search for: "United States v. Sandoz" Results 21 - 40 of 203
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2020, 2:05 pm by SCOTUStalk
And I was representing the United States as an amicus to Ohio, and I had not actually written the briefs in this case. [read post]
9 Mar 2020, 1:21 pm by Unknown
Some state laws on this may also have to be addressed.Why are 11 of 26 biosimilars approved not actively marketed in the US? [read post]
18 Apr 2019, 4:47 am by Brian Cordery
As regards discretion, Sandoz pointed to alleged financial troubles facing Purdue Pharma arising from the litigation regarding Oxycontin in the United States. [read post]
27 Nov 2018, 9:30 am by Ronald Mann
CLS Bank), and equally far from the intricate statutory problems presented in cases like Sandoz v Amgen (assessing procedures for approving biosimilar pharmaceuticals). [read post]
17 Oct 2018, 7:49 pm by Brian Craig
Sandoz Inc., United States Court of Appeals, Federal Circuit, No. 2017-1575, 12 October 2018 appeared first on Kluwer Patent Blog. [read post]
21 Sep 2018, 4:47 am by Dennis Crouch
Samsung Electronics America, Inc. et al., No. 18-189 (Three good questions): Whether Administrative Patent Judges of the [PTAB] are principal Officers of the United States who must be appointed by the President with the advice and consent of the Senate under the Appointments Clause. [read post]
4 Sep 2018, 9:43 am by Lawrence B. Ebert
., Telefonaktiebolaget LMEricsson, and United States Cellular Corporation (collectively,“T-Mobile”) have not infringed U.S. [read post]
27 Aug 2018, 3:11 pm by Afro Leo
  A happy outcome in the United States was the decision here  in Christian Louboutin S.A. v Yves Saint Laurent America Inc., No. 11-3303 (2d Cir. 2012) 1 ‘…the Red Sole Mark has acquired limited secondary meaning as a distinctive symbol that identifies the Louboutin brand, and…it is therefore a valid and protectable mark…’ (page 25) here.A second problem featured in the recent decision of the Court of Justice of the European Union… [read post]
23 Jul 2018, 12:05 pm by Dennis Crouch
United States Postal Service, No. 17-1594 (Whether the government is a “person” who can petition to institute a CBM;  Does a 1498(a) action count as an infringement action?) [read post]
29 Jun 2018, 7:50 am by Jason Rantanen
Dispute Over Method 207 The United States Pharmacopeial Convention (USP) is an SDO that develops standards for testing the quality and purity of foods and drugs. [read post]
7 Jun 2018, 12:16 pm by Lawrence B. Ebert
The early dismissal would be final as to that claim, see United States v. [read post]
20 Jul 2017, 10:00 pm
Post By Blog Staff Earlier this week, the Unites States Court of Appeals for the Federal Circuit (“CAFC”) held that the United States District Court for the District of Delaware clearly erred in its obviousness analysis in Millennium Pharmaceuticals, Inc. v. [read post]